TITLE

Rapid increase in serum levels of matrix metalloproteinase-9 (MMP-9) postoperatively is associated with a decrease in the amount of intracellular MMP-9

AUTHOR(S)
Belizon, Avraham; Kirman, Irena; Karten, Moshe; Jain, Suvinit; Whelan, Richard L.
PUB. DATE
December 2005
SOURCE
Surgical Innovation;Dec2005, Vol. 12 Issue 4, p333
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
We have previously demonstrated a significant decrease in the serum concentration of intact insulin-like growth factor-binding protein (IGFBP-3) after laparotomy. IGFBP-3, a major IGF binding protein, inhibits the growth of tumor cells via several mechanisms. Our goal was to determine, in a murine model, whether matrix metalloproteinase-9 (MMP-9), a known protease of IGFBP-3, is responsible for the postoperative decrease in serum IGFBP-3 levels. Six IGFBP-3 transgenic mice on a CD-1 background were used in this study. These mice over-express human IGFBP-3. Sham laparotomy, in the form of a midline abdominal incision, was the test procedure. General anesthesia was established using ketamine and xylazine immediately before a 30-minute sham laparotomy and before preoperative blood sampling, done via retro-orbital venipuncture, 48 hours before surgery. The animals were sacrificed and blood was drawn 24 hours postoperatively. Plasma MMP-9 activity was measured using zymography at each time point (48 hours before and 24 hours after operation). MMP-9 activity was also measured in mononuclear cell lysates at both time points. Zymography analysis demonstrated significantly higher plasma levels of MMP-9 postoperatively compared with preoperative levels (81 RU vs 40 RU; P < .05). In contrast, mononuclear cell levels of MMP-9 were significantly higher preoperatively compared with postoperative levels (37.5 RU vs. 0.75 RU, P < .05). Plasma levels of MMP-9, a known protease of IGFBP-3, are significantly elevated postoperatively. In addition, mononuclear cells that store MMP-9 are depleted of it postoperatively. This suggests that rapid MMP-9 release by mononuclear cells leads to an increase in serum levels of this protease postoperatively. Further studies will elucidate mechanisms of MMP-9-related IGFBP-3 depletion.
ACCESSION #
19487626

 

Related Articles

  • IGFBP-1 forms associated with placental cell membranes. Masnikosa, Romana; Živković, Bogovid; Nedić, Olgica // Journal of the Serbian Chemical Society;Jul2009, Vol. 74 Issue 7, p707 

    Fetal growth in utero depends on the proper development and function of the placenta. Insulin-like growth factors (IGFs) are critically involved in placental development. During pregnancy, an IGF-binding protein, IGFBP-1, which is produced by maternal decidua, plays an important role in the...

  • Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9. Belizon, A.; Kirman, I.; Balik, E.; Karten, M.; Jain, S.; Whelan, R.; Whelan, R L // Surgical Endoscopy;Apr2007, Vol. 21 Issue 4, p653 

    Background: The authors previously demonstrated a significant decrease in plasma levels of intact insulin-like growth factor binding protein-3 (IGFBP-3) after major open but not after laparoscopic-assisted surgery in humans. They postulated that this decrease may have an effect on...

  • Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis. Wilczak, N.; Ramsaransing, G. S. M.; Mostert, J.; Chesik, D.; de Keyser, J. // Multiple Sclerosis (13524585);Feb2005, Vol. 11 Issue 1, p13 

    Using radioimmunoassay we measured serum levels of insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-3 in patients with relapsing multiple sclerosis (MS) and a benign course (Expanded Disability Status Scale (EDSS) = 3 despite > 10 years disease duration), relapsing MS with...

  • Insulin-Like Growth Factors | Binding.  // Current Medical Literature: GH & Growth Factors;2003, Vol. 18 Issue 3, p78 

    Discusses abstracts on insulin-like growth factors and binding proteins. "The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study," by M.S. Boyne et al; "A novel insulin-like growth factor...

  • Insulin-like Growth Factor (IGF) Binding Protein Proteases: Key Regulators of IGF Action. Conover, Cheryl A. // Current Medical Literature: GH & Growth Factors;2004, Vol. 19 Issue 3, p57 

    Discusses the function of insulin-like growth factor binding protein proteases (IGFBP) proteolysis in normal physiology. Characterization of IGFBP protease; Details on the interaction of insulin-like growth factor with receptors; Implications of IGFBP in human physiology and pathophysiology.

  • Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Gram, I. T.; Norat, T.; Rinaldi, S.; Dossus, L.; Lukanova, A.; Téhard, B.; Clavel-Chapelon, F.; van Gils, C. H.; van Noord, P. A. H.; Peeters, P. H. M.; Bueno-de-Mesquita, H. B.; Nagel, G.; Linseisen, J.; Lahmann, P. H.; Boeing, H.; Palli, D.; Sacerdote, C.; Panico, S.; Tumino, R.; Sieri, S. // International Journal of Obesity;Nov2006, Vol. 30 Issue 11, p1623 

    Objective: To examine the relationship between body mass index (BMI) and waist-hip ratio (WHR) with serum levels of insulin-like growth factor-I (IGF-I), and its binding protein (IGFBP)-3.Design: Cross-sectional study on 2139 women participating in a case-control study...

  • Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Hassfeld, Sabine; Eichhorn, Christina; Stehr, Katla; Naegele, Herbert; Geier, Christian; Steeg, Martin; Ranke, Michael B.; Oezcelik, Cemil; Osterziel, Karl Josef // Heart;Mar2007, Vol. 93 Issue 3, p359 

    The article discusses a study which examined the role of insulin-like growth factor (IGF)-binding proteins (BP) 2 and 3 as predictors of a poor prognosis in patients with idiopathic dilated cardiomyopathy. The study demonstrated that low IGF1 and IGFBP3 levels and high IGFBP2 levels are...

  • Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 weeks in preeclampsia. Sifakis, S; Akolekar, R; Kappou, D; Mantas, N; Nicolaides, K H // Journal of Human Hypertension;Apr2012, Vol. 26 Issue 4, p253 

    The objective of this study was to determine if the maternal serum concentration of insulin-like growth factor-binding protein-3 (IGFBP-3) at 11-13 week's gestation is altered in pregnancies that subsequently develop preeclampsia (PE). Maternal serum concentration of IGFBP-3,...

  • Somatomedin-1 binding protein-3.  // BioDrugs;2003, Vol. 17 Issue 5, p375 

    Somatomedin-1 binding protein-3 [insulin-like growth factor-1 binding protein-3, SomatoKine®] is a recombinant complex of insulin-like growth factor-1 (rhIGF-1) and binding protein-3 (IGFBP-3), which is the major circulating somatomedin (insulin-like growth factor) binding protein; binding...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics